Short Interest in WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Declines By 59.3%

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) was the recipient of a large decrease in short interest in the month of January. As of January 30th, there was short interest totaling 9,096 shares, a decrease of 59.3% from the January 15th total of 22,350 shares. Based on an average daily volume of 54,542 shares, the short-interest ratio is currently 0.2 days. Based on an average daily volume of 54,542 shares, the short-interest ratio is currently 0.2 days.

WuXi Biologics (Cayman) Price Performance

OTCMKTS:WXXWY opened at $10.55 on Friday. The business’s 50-day moving average is $9.19 and its two-hundred day moving average is $9.03. WuXi Biologics has a 12 month low of $4.14 and a 12 month high of $11.21.

WuXi Biologics (Cayman) Company Profile

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.